Keith Wright, MD
MOHS-Micrographic Surgery · Snellville, GANPI 1649214537
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 245 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 47.2% of the total. Reporting peaked in 2022 at $1,192 and has fallen 55.2% since, to $534 in 2025.
Across 245 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sanofi$662
- Johnson & Johnson$319
- LEO Pharma Inc.$172
- UCB, Inc.$167
- Sun Pharmaceutical Industries Inc.$149
- plus $1K from 22 others
What the payments were for
- Grants$701%
- Food & beverage$4,83599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 122 | $2,314 |
| Sanofi | 25 | $662 |
| Johnson & Johnson | 16 | $319 |
| LEO Pharma Inc. | 9 | $172 |
| UCB, Inc. | 7 | $167 |
| Sun Pharmaceutical Industries Inc. | 9 | $149 |
| Almirall LLC | 9 | $129 |
| Pfizer | 7 | $116 |
| Regeneron Healthcare Solutions, Inc. | 5 | $108 |
| Amgen | 4 | $96 |
| Incyte Corporation | 4 | $96 |
| VYNE Pharmaceuticals Inc. | 3 | $74 |
| Lilly USA, LLC | 3 | $61 |
| Biofrontera Inc. | 3 | $58 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $55 |
| DUSA Pharmaceuticals, Inc. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 3 | $44 |
| Janssen Scientific Affairs, LLC | 1 | $35 |
| Organogenesis Inc. | 1 | $35 |
| Dermavant Sciences, Inc. | 1 | $25 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| Boehringer Ingelheim | 1 | $23 |
| Hydrofera LLC | 1 | $22 |
| Dermira, Inc. | 1 | $19 |
| Mission Pharmacal Company | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| Organon | 1 | $13 |
| Reprise Biomedical, Inc. | 1 | $11 |
How this compares
$4,905 in reported general payments places this provider in the 60th percentile of 40 mohs-micrographic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 281 | $1,024 |
| Doxycycline Hyclate | 61 | $323 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $33 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Snellville
- Wallace NozileStockbridge$213K
- Brandon BurrowayDuluth$30K
- John KayalMarietta$27K
- David HarveyNewnan$17K
- David OlanskyAtlanta$13K
- David KentMacon$11K
- Diamondis PapadopoulosAtlanta$9K
- Sidney SmithSavannah$9K
- Steven KentMacon$8K
- Danielle LazzaraMilton$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.